Prostamax Peptide: Prostate Tissue and Cellular Aging Research

Scientifically reviewed by
Dr. Ky H. Le, MD

The information presented in this article is for educational and research purposes only, intended for laboratory professionals, researchers and collaborators. This content does not constitute medical or clinical advice.

Prostamax is a synthetic tetrapeptidebioregulator with the amino acid sequence Lys-Glu-Asp-Pro (KEDP). Research places this 487.5 g/mol compound in the Khavinsonpeptide family. Laboratory studies show it can change chromatin structure and affect gene expression patterns in various tissue types, notably prostate tissue.

The peptide works through epigenetic mechanisms instead of directly modifying the genome. Studies indicate it helps adjust chromatin accessibility, affecting which genes are available for transcription without changing the underlying DNA sequences.

This makes Prostamax a valuable research tool for studying chromatin remodeling, gene regulation, and tissue-specific cellular responses in controlled laboratory settings.

Key Highlights

• Prostamax induces measurable changes in chromatin thermal stability, causing relaxation of the 30-nm chromatin fiber into 10-nm filaments in human lymphocyte studies
• Research demonstrates significant activation of ribosomal genes and increased nucleolus organizer regions in treated cell cultures
• Studies in prostate tissue models show 22.4% reduction in acini epithelium area with corresponding decreases in inflammatory markers
• The peptide shows selective deheterochromatinization effects, potentially reversing age-related chromatin condensation patterns observed in aged cell populations

What is Prostamax Peptide Bioregulator?

Prostamax is a synthetic tetrapeptide bioregulator consisting of four amino acids: lysine, glutamic acid, aspartic acid, and proline. The sequence KEDP belongs to a class of short peptides developed through decades of Russian bioregulator research^[1].

The molecular weight of 487.5 g/mol allows the peptide to interact with cellular structures at multiple levels. Research focuses primarily on its effects on chromatin organization, gene expression, and tissue-specific cellular responses in laboratory models.

Unlike receptor-mediated signaling peptides, Prostamax appears to function through structural modulation of the DNA-protein complex. This mechanism positions it as a research tool for studying epigenetic regulation and chromatin dynamics in controlled experimental settings^[1].

Related Product: Buy Prostamax Peptide for laboratory research use.

How Prostamax Modulates Chromatin Structure

Chromatin Relaxation and Thermal Stability Changes

Differential scanning calorimetry studies on human lymphocytes reveal that Prostamax induces measurable changes in chromatin thermal stability. The peptide causes a redistribution of heat among endotherms T(d)III and T(d)IV, with temperature shifts of 2.9°C and 1.0°C respectively^[2].

This thermal redistribution correlates with a relaxation in chromatin structure. The research shows a transition of the 30-nm-thick fiber into a 10-nm filament, suggesting the peptide alters the compaction state of chromatin.

The mechanism involves subtle structural modifications in nucleosomal organization. Treated lymphocytes show decreased denaturation temperatures (T(d)VII and T(d)VIII) compared to controls, indicating adjustments in both the 10-nm filament and 30-nm fiber architecture^[2].

These changes in chromatin organization may influence gene accessibility. The relaxed chromatin state could allow transcriptional machinery greater access to previously condensed genomic regions.

Heterochromatin Decondensation in Aged Cells

Research on aged lymphocyte cultures (75-88 years) shows that Prostamax induces deheterochromatinization across multiple chromatin regions. The peptide affects both structural and facultative heterochromatin through epigenetic remodeling mechanisms^[3].

Studies document effects on constitutive heterochromatin, including pericentromeric regions, telomeric areas, and nucleolar organizer regions (NORs). Increased sister chromatid exchanges in telomeric regions indicate chromatin decondensation at these sites^[3].

Each peptide bioregulator selectively deheterochromatinizes specific chromosome regions. This selectivity suggests the peptide may release genes repressed by age-related chromatin condensation in targeted genomic locations.

The proposed mechanism involves reversal of age-related heterochromatinization. This progressive condensation of chromatin observed during aging silences previously active genes, and peptide treatment may restore accessibility to these repressed regions.

Gene Expression and Transcriptional Mechanisms

Ribosomal Gene Activation

Ag-staining techniques show that Prostamax increases Ag-positive nucleolus organizer regions (NORs) in acrocentric chromosomes, both in association and isolation. This finding indicates activation of ribosomal genes and increased potential for protein synthesis^[3].

The changes in NOR activity suggest the peptide influences ribosomal RNA gene transcription. These genes code for components needed in ribosome assembly, and their activation could affect overall cellular protein production capacity.

Research shows Prostamax appears to increase gene expression at multiple levels through its influence on ribosomes and densely packed chromatin in lymphocytes. This establishes conditions for heightened transcriptional activity in treated cell populations^[2].

DNA-Peptide Binding Interactions

Khavinson peptides, including those with sequences similar to KEDP, demonstrate sequence-specific binding to double-stranded DNA in promoter regions. Short peptides containing Lys, Glu, Asp residues can bind to histone proteins H1, H2b, H3, and H4^[1].

This binding capacity allows the peptides to increase transcription availability of gene promoter zones. Research shows these interactions modulate genes involved in neurogenesis (NES, GAP43), senescence (p16, p21), and functional activity (IGF-1, FOXO1, TERT).

The tripeptide Lys-Glu-Asp (KED), sharing three amino acids with Prostamax, regulates expression of cell aging markers (p16, p21). It also affects neuronal differentiation markers (nestin, GAP43) and genes implicated in neuropathology (SUMO, APOE, IGF1)^[4].

Research Observations in Specific Tissues

Prostate Tissue Culture Studies

In experimental models using sulpiride-induced benign prostatic hyperplasia in rats, the tetrapeptide Lys-Glu-Asp-Pro showed 22.4% reduction in the area of acini epithelium compared to controls. The study documented statistically significant decreases in prostate mass (24%), weight coefficient (25%), and volume (40%)^[5].

The peptide treatment transformed inflammatory cell infiltration patterns from diffuse to localized. This change suggests modulation of immune cell distribution within prostate tissue structures.

Research in prostatic gland tissue cultures indicates the peptide may support reparative processes. Studies note reductions in markers associated with sclerotic and atrophic changes in treated tissue samples.

Chronic aseptic prostatitis models show potential alleviation of inflammation-related observations including swelling, vessel hyperemia, and cellular infiltration^[5]. These findings position Prostamax as a research tool for investigating prostate tissue responses in controlled experimental conditions.

Lymphocyte and Immune Cell Research

The tripeptide Lys-Glu-Asp demonstrates proliferation-stimulating and apoptosis-inhibiting activity in organotypic cultures of neuroimmunoendocrine system cells. Studies show decreased expression of apoptosis marker p53 and increased proliferation marker Ki-67 in pineal gland cultures^[6].

Effects appear more pronounced in cultures derived from aged animals compared to young animals. This age-dependent response suggests the peptide may preferentially affect cellular populations experiencing age-related changes.

Research documents increased expression of lymphocyte marker CD5 and macrophage marker CD68 in treated cultures. These changes indicate modulation of immune cell phenotypes and potential shifts in immune cell populations^[6].

The peptide appears to affect gene expression at multiple levels through its influence on chromatin structure in lymphocytes. This creates conditions that may allow for altered transcriptional programs in immune cells.

Third-Party Tested, USA-Made, 99% Purity

Lyophilized peptides for laboratory applications. 99% purity, 100% USA-Made.

Cellular Aging and Proliferation Research

Short peptides containing the Lys-Glu-Asp sequence stimulate proliferation and inhibit apoptosis in pineal gland tissue cultures. Research shows effects are more pronounced in aged cell populations, measured by decreased p53 expression and increased Ki-67 expression^[6].

Related peptides (KED, AEDG) reduce gene expression and synthesis of replicative senescence proteins p16 and p21 in mesenchymal stem cell cultures^[1]. This suggests potential modulation of cell cycle arrest pathways associated with cellular aging.

The mechanism appears to involve reversal of age-related heterochromatinization. This progressive condensation of chromatin during aging silences previously active genes, and peptide treatment may restore accessibility to repressed genomic regions.

Research contexts span in vitro cell cultures, organotypic tissue preparations, and animal models. Observations derive primarily from Russian academic institutions specializing in bioregulatory peptide research.

Research Applications for Prostamax

Research Application	Experimental Context	Key Observations
Chromatin remodeling studies	Human lymphocyte cultures	30-nm to 10-nm fiber transitions, thermal stability changes
Epigenetic aging research	Aged cell populations (75-88 years)	Selective deheterochromatinization, increased NOR activity
Gene expression modulation	Multiple cell types	Ribosomal gene activation, histone protein binding
Prostate tissue research	Animal hyperplasia models	22.4% epithelium reduction, decreased inflammatory markers
Cellular senescence studies	Stem cell cultures	Reduced p16/p21 expression, altered proliferation markers
Immune cell investigations	Organotypic cultures	Modified CD5/CD68 expression, altered apoptosis pathways

Quality Standards and Analytical Verification

Research-grade Prostamax requires verification through multiple analytical methods. High-performance liquid chromatography (HPLC) confirms purity levels above 99%, while liquid chromatography-mass spectrometry (LC-MS) verifies molecular structure and sequence accuracy.

BioLongevity Labs manufactures Prostamax in USA GMP facilities with triple third-party testing verification. Each batch ships with certificates of analysis from three independent certified laboratories, providing researchers with comprehensive analytical documentation.

The testing protocols include sterility verification, endotoxin screening, and chemical contaminant analysis. This multi-layered approach allows research teams to verify peptide quality before initiating experimental protocols.

Storage at -20°C maintains lyophilized peptide stability for 3-5 years. Reconstituted peptides require sterile conditions and shorter-term use to preserve molecular integrity throughout experimental timelines.

Research peptides from BioLongevity Labs include complete documentation packages with MSDS, COA, and analytical dossiers. Same-day shipping for orders placed before 12pm PT supports uninterrupted research schedules.

Note: All peptides are strictly for research use only.

---

---

References

1. 1. Khavinson VK, Popovich IG, Linkova NS, Mironova ES, Ilina AR. Peptide Regulation of Gene Expression: A Systematic Review. MDPI AG; 2021. https://doi.org/10.3390/molecules26227053
2. 2. Meskhi T, Khachidze D, Barbakadze S, Madzhagaladze G, Gorgoshidze M, Monaselidze D, et al. [The influence of the peptide bioregulator prostamax on heterochromatin of human lymphocytes in situ]. Biofizika 2004;49 6:1091–3.
3. 3. Lezhava T, Jokhadze T, Monaselidze J, Buadze T, Gaiozishvili M, Sigua T. EPIGENETIC MODIFICATION UNDER THE INFLUENCE OF PEPTIDE BIOREGULATORS ON “AGED” HETEROCHROMATIN. Georgian medical news 2020;309:120–124.
4. 4. Khavinson VKh, Lin’kova NS, Umnov RS. Peptide KED: Molecular-Genetic Aspects of Neurogenesis Regulation in Alzheimer’s Disease. Springer Science and Business Media LLC; 2021. https://doi.org/10.1007/s10517-021-05192-6
5. 5. Borovskaya TG, Fomina TI, Shchemerova JA, Poluektova ME, Vychuzhanina AV, Kamalova SI, et al. Experimental Study of Efficiency of Tertapeptide Lysil-Glutamyl-Aspartyl- Proline Using the Model of Benign Prostatic Hyperplasia. Scientific Research Publishing, Inc.; 2014. https://doi.org/10.4236/mri.2014.33013
6. 6. Chalisova NI, Lopatina NG, Kamishev NG, Linkova NS, Koncevaya EA, Dudkov AV, et al. Effect of Tripeptide Lys-Glu-Asp on Physiological Activity of Neuroimmunoendocrine System Cells. Springer Science and Business Media LLC; 2012. https://doi.org/10.1007/s10517-012-1768-7